C12-200 Lipid (CAS: 1220890-25-4) – Advanced Branched Ionizable Lipid for Nanoparticle Delivery
C12-200 Lipid is a potent branched ionizable lipid with the CAS number 1220890-25-4, known for its effectiveness in lipid nanoparticle (LNP) formulations. This lipid features a branched tail structure and is utilized to enhance the delivery of biologically active substances into cells and intracellular compartments.
Key Features
- Branched Ionizable Structure: Enhances the lipid’s ability to form stable nanoparticles and improve drug delivery.
- Molecular Weight: Approximately 200 Da, tailored for effective biocompatibility and performance.
- Efficient Delivery: Facilitates the transport of small molecules, proteins, and nucleic acids into cells.
Applications
- Lipid Nanoparticle (LNP) Formation: Used in combination with other lipids to create LNPs for delivering siRNA, mRNA, and vaccines.
- Enhanced Drug Delivery: Improves the delivery efficiency of biologically active substances.
- Advanced Therapeutics: Demonstrates superior performance in formulations like erythropoietin-mRNA-loaded nanoparticles.
Advantages
- Potent Delivery: Significantly increases the potency and effectiveness of therapeutic nanoparticles.
- Enhanced Performance: Shows a 7-fold improvement in efficacy for specific formulations.
- Versatile Use: Ideal for a wide range of applications in drug delivery and nanoparticle development.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.